Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Delek US Holdings (DK)17,000 shares of common stock at a weighted average price of $41.42 and 10,000 shares at a weighted average price of $41.25. Following these sales, the reporting person beneficially owns 23,020 shares, held directly.
The filing notes the trades were executed under a Rule 10b5-1 trading plan adopted on March 6, 2025 and amended August 13, 2025. Price ranges were disclosed: $41.39–$41.59 for the first set and $41.16–$41.37 for the second.
Delek US Holdings (DK) reported insider activity by EVP Joseph Israel. On 11/11/2025, he sold 20,028 shares of common stock at a weighted average price of $41.115 (range: $40.935–$41.26). The same day, 2,652 shares were withheld for taxes upon equity award vesting at $41.70. On 11/12/2025, he sold an additional 4,380 shares at a weighted average price of $40.942 (range: $40.60–$41.11).
Following these transactions, Israel directly beneficially owned 55,761 shares.
Delek US Holdings (DK): EVP insider sale reported. An executive vice president sold 5,643 shares of common stock on 11/11/2025 at a weighted average price of $41.462, with trades ranging from $41.45 to $41.51, leaving 41,269 shares directly owned after this transaction. On 11/12/2025, the EVP sold an additional 2,303 shares at a weighted average price of $40.427, with trades ranging from $40.37 to $40.48, resulting in 38,966 shares directly owned afterward.
Delek US Holdings (DK) reported an insider transaction on a Form 4. Director Ezra Uzi Yemin sold common stock on 11/07/2025 pursuant to a Rule 10b5-1 plan. Two sales were reported at a weighted average price of $43.09, reflecting multiple trades between $43.00 and $43.39 per share.
Following these transactions, beneficial ownership stands at 154,719.047 shares direct and 679,656 shares indirect held by Yemin Investments, LP.
Delek US Holdings (DK) filed a Form 144 indicating a proposed sale of 28,494 common shares. The filing lists an approximate sale date of 11/11/2025, an aggregate market value of $1,166,605.81, and identifies Merrill Lynch as broker, with trading on the NYSE.
The shares were acquired through the vesting of stock awards on multiple dates between 12/09/2023 and 11/11/2025, as shown in the acquisition table. This notice outlines an intention to sell under Rule 144 and includes the required representation regarding knowledge of material nonpublic information.
Goldman Sachs Group and Goldman Sachs & Co. LLC filed a Schedule 13G on Delek US Holdings (DK), reporting beneficial ownership of 3,171,695.56 shares, or 5.3% of the common stock, as of 09/30/2025. The filing lists shared voting power over 3,171,276.56 shares and shared dispositive power over 3,171,427.56 shares, with no sole voting or dispositive power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Delek US Holdings. The 13G indicates a passive ownership position consistent with routine institutional reporting thresholds.
DK filed a Rule 144 notice for a proposed sale of common stock. The filing lists 2,303 shares to be sold on the NYSE through Fidelity Brokerage Services, with an aggregate market value of $93,103.66 and 60,051,553 shares outstanding. The approximate sale date is 11/12/2025.
The shares were acquired via the company’s Employee Stock Purchase Plan: 948 shares on 03/28/2024 (cash) and 1,355 shares on 03/31/2025 (cash). The notice includes the standard representation regarding the absence of undisclosed material adverse information.
DK filed a Form 144 notice for the proposed sale of 5,643 shares of Common Stock. The filing lists an aggregate market value of $233,972.32, with an approximate sale date of 11/11/2025. The shares are to be sold through Citigroup Global Markets Inc. on the NYSE. Shares outstanding are reported as 60,051,553.
The securities to be sold were acquired on 06/09/2025 as compensation from the issuer, in the same amount of 5,643 shares. The filing also notes a prior transaction in the last three months: Robert Wright sold 7,135 shares of Common Stock on 09/02/2025 for $208,659.51.
Delek US (DK)17,000 shares of common stock. The filing lists an aggregate market value of $703,970, with sales through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/11/2025.
The shares to be sold were acquired via restricted stock vesting on multiple dates, including 06/12/2022 (330), 03/10/2023 (2,141), 09/10/2024 (3,119), 06/10/2025 (1,487), and 09/10/2025 (4,482). The filing lists 60,051,553 shares outstanding.
Form 144 notice of proposed sale: A holder filed to sell 10,000 shares of common stock under Rule 144. The filing lists an aggregate market value of $414,100 and identifies Fidelity Brokerage Services LLC as broker, with sales on the NYSE and an approximate sale date of 11/11/2025. The shares were acquired through restricted stock vesting on multiple dates between 09/12/2022 and 06/10/2024.
Shares outstanding were 60,051,553 as of the filing; this is a baseline figure, not the amount being sold.